Cargando…

A new prognostic hypoxia biomarker consisting of imaging and gene-based data

Detalles Bibliográficos
Autores principales:	Thomas, Elisa, Krause, Mechthild
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393522/ https://www.ncbi.nlm.nih.gov/pubmed/32739865 http://dx.doi.org/10.1016/j.ebiom.2020.102901

Ejemplares similares

A new roadmap to improve translation of imaging biomarkers
por: Skwarski, Michael, et al.
Publicado: (2016)

Active Inference and Cognitive Consistency
por: Friston, Karl J.
Publicado: (2018)

Genes for the high life: New genetic variants point to positive selection for high altitude hypoxia in Tibetans
por: Jablonski, Nina G.
Publicado: (2017)

Targeting hypoxia in tumor: a new promising therapeutic strategy
por: Bosco, Maria Carla, et al.
Publicado: (2020)

A new approach to hypobaric hypoxia induced cognitive impairment
por: Babbar, Rashmi, et al.
Publicado: (2012)

Hypoxia therapy--a new hope for the treatment of mitochondrial dysfunctions
por: Huang, Jun-long, et al.
Publicado: (2016)

Maximizing the benefits of improved cookstoves: moving from acquisition to correct and consistent use
por: Shankar, Anita, et al.
Publicado: (2014)

Predicting Treatment Outcomes: The Case for Hypoxia Gene Signatures
por: Marignol, Laure
Publicado: (2018)

IFNγ signaling response in peripheral blood monocytes: A new prognostic biomarker for breast cancer?
por: Deschoemaeker, Sofie, et al.
Publicado: (2020)

Taxonomic species recognition should be consistent
por: O’Brien, Stephen J, et al.
Publicado: (2023)

Advances in quantitative magnetic resonance imaging-based biomarkers for Alzheimer disease
por: Dickerson, Bradford C
Publicado: (2010)

Prognostic value of biomarkers in primary small cell carcinoma of the esophagus
por: Wang, Yan, et al.
Publicado: (2020)

A prognostic signature consisting of N6-methyladenosine modified mRNAs demonstrates clinical potential in prediction of biochemical recurrence and guidance on precision therapy in prostate cancer
por: Lu, Jianming, et al.
Publicado: (2023)

Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapy
por: Linge, Annett, et al.
Publicado: (2016)

Canada Should Move Toward Adopting Harmonized Evidence-Based OELs to Consistently and Adequately Protect Workers
por: Barn, Prabjit, et al.
Publicado: (2020)

Consistency and coherence in treatment outcome measures for borderline personality disorder
por: Madan, Alok, et al.
Publicado: (2015)

The case for consistent use of medical eponyms by eliminating possessive forms
por: Ayesu, Kwabena, et al.
Publicado: (2018)

Surrogate Prognostic Biomarkers in OSCC: The Paradigm of PA28γ Overexpression
por: Kontos, Christos K.
Publicado: (2015)

Biomarkers of Intestinal Injury and Dysfunction: Adding New Possibilities to Current Methods for Risk Stratification of Children with Malaria Disease
por: Balanza, Núria, et al.
Publicado: (2022)

Laboratory biomarkers or imaging in the diagnostics of rheumatoid arthritis?
por: Šenolt, Ladislav, et al.
Publicado: (2014)

Commentary: Hyperreflective dots - An imaging biomarker of inflammation?
por: Agarwal, Aniruddha
Publicado: (2019)

Methylation of PD-1 Promoter Gene as New Prognostic Marker for IDH Mutant Low-Grade Glioma?
por: Marosi, Christine
Publicado: (2018)

Ensuring trial conduct is consistent with trial design: assumption is the enemy of quality
por: Kelly, Joanna, et al.
Publicado: (2019)

Apolipoprotein M - a new biomarker in sepsis
por: Christoffersen, Christina, et al.
Publicado: (2012)

Copeptin: a new and promising diagnostic and prognostic marker
por: Katan, Mira, et al.
Publicado: (2008)

Food Sublingual Immunotherapy Using Consistent, Cheaper and Customizable Oral Immunotherapy Solutions
por: Gendo, Karna, et al.
Publicado: (2021)

Tenascin-C: an emerging prognostic biomarker in diabetes
por: Yonebayashi, Saori, et al.
Publicado: (2020)

New Biomarkers for Early Detection of Hepatocellular Carcinoma
por: Yoshida, Katsunori
Publicado: (2015)

Developing a personalized treatment model based on molecular biomarkers and imaging in breast cancer: Has the time come?
por: Choudhury, Partha
Publicado: (2016)

PSP/reg: a new stone in sepsis biomarkers?
por: Busani, Stefano, et al.
Publicado: (2012)

Biomarkers for Treatment Monitoring in Tuberculosis: A New Hope
por: Babu, Subash
Publicado: (2017)

Consistency of Response to Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Over 1 Year
por: Blauvelt, Andrew, et al.
Publicado: (2022)

Spitting image: can saliva biomarkers reflect Alzheimer's disease?
por: Ashton, Nicholas J., et al.
Publicado: (2021)

Searching for non-invasive markers of tissue hypoxia
por: Puyana, Juan Carlos, et al.
Publicado: (2007)

Targeting the hypoxia pathway to treat pancreatic cancer
por: Erickson, Lori A, et al.
Publicado: (2015)

Epigenetics in rhabdomyosarcoma: cues to new biomarkers and targeted therapies
por: Megiorni, Francesca
Publicado: (2020)

Quantifying the added value of new biomarkers: how and how not
por: Cook, Nancy R.
Publicado: (2018)

Soluble RAGE: a hot new biomarker for the hot joint?
por: Moser, Bernhard, et al.
Publicado: (2005)

Biomarkers in acute kidney injury: On the cusp of a new era?
por: Canney, Mark, et al.
Publicado: (2023)

Challenges and Technological Trends Toward Improved Medical Imaging-based Predictive Data-mining
por: Zaritsky, Assaf
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ndvctub8cqucknhkoea5jd9t9e